Damora Therapeutics, Inc.(DMRA:US)
Market Cap$1.13B
Key Metrics
Price$18.74
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$235.09M
EBITDA (TTM)-$238.91M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$540.52M
Total Assets$543.64M
Net Assets$516.06M
Total Debt$0
Key Metrics
Price$18.74
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$235.09M
EBITDA (TTM)-$238.91M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$540.52M
Total Assets$543.64M
Net Assets$516.06M
Total Debt$0
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 |
|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
| $30.81M | $201.7M | $3.16M | $3.42M | $2.6M | $7.1M | |
| Research and Development | $23.78M | $197.63M | $1.42M | $1.47M | $678K | $5.4M |
| Selling, General, and Administrative | $7.03M | $4.07M | $1.74M | $1.96M | $1.92M | $1.7M |
| Other Operating Expenses | - | - | - | - | - | - |
Operating Income | -$30.81M | -$201.7M | -$3.16M | -$3.42M | -$2.6M | -$7.1M |
| $3.07M | $1M | $23K | -$12K | $68K | $353K | |
| Non-Operating Interest Income | $3.07M | $1M | $42K | $50K | $74K | $228K |
| Non-Operating Interest Expense | - | - | - | - | - | - |
| Other Income/Expense | - | $3K | -$19K | -$62K | -$6K | $125K |
Income Before Tax | -$27.74M | -$200.69M | -$3.13M | -$3.43M | -$2.53M | -$6.75M |
Income Tax | $42K | $44K | $0 | $4K | $2K | -$8K |
Net Income | -$27.78M | -$200.74M | -$3.13M | -$3.44M | -$2.53M | -$6.74M |
Minority Interests | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - |
Net Income to Common | -$27.78M | -$200.74M | -$3.13M | -$3.44M | -$2.53M | -$6.74M |
Shares Outstanding (Basic) | 34.3M | - | 1.33M | 1.32M | 1.32M | - |
Shares Outstanding (Diluted) | 34.3M | - | 1.33M | 1.32M | 1.32M | - |
EPS (Basic) | -$0.62 | - | -$2.36 | -$2.60 | -$1.92 | - |
EPS (Diluted) | -$0.62 | - | -$2.36 | -$2.60 | -$1.92 | - |
EBIT | -$30.81M | -$201.7M | -$3.16M | -$3.42M | -$2.6M | -$7.1M |
EBITDA | -$30.74M | -$201.69M | -$3.13M | -$3.35M | -$2.59M | -$7.23M |